SCHEMBL13699744

SCHEMBL13699744

Cc1ccc2oc(C(N)=O)c(NC(=O)c3cccc(CCl)c3)c2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 6/20 0.53
HSD17B10 Q99714 5/20 0.53
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
MAPK10 P53779 4/20 0.53
TSHR P16473 4/20 0.53
NPSR1 Q6W5P4 1/20 0.53
KDM4E B2RXH2 4/20 0.53
ALDH1A1 P00352 4/20 0.52
THRB P10828 2/20 0.48
MAPT P10636 6/20 0.46
TP53 P04637 5/20 0.46
LMNA P02545 1/20 0.46
ALOX15 P16050 1/20 0.46
AHR P35869 1/20 0.46
TEAD1 P28347 1/20 0.46
YAP1 P46937 1/20 0.46
TEAD4 Q15561 1/20 0.46
TEAD2 Q15562 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13699921 0.92 MAPK10 (0.53) HPGDHSD17B10MEN1KMT2AMAPK10
SCHEMBL13699743 0.88 KMT2A (0.53) HPGDHSD17B10MEN1KMT2AMAPK10
SCHEMBL13699735 0.88 MAPT (0.56) HPGDHSD17B10MEN1KMT2AMAPK10
SCHEMBL13699905 0.85 MAPK10 (0.48) HPGDHSD17B10MEN1KMT2AMAPK10
SCHEMBL13699695 0.84 MAPT (0.57) HPGDHSD17B10MEN1KMT2AMAPK10
SCHEMBL13699737 0.82 ALDH1A1 (0.53) HPGDHSD17B10MEN1KMT2AMAPK10
SCHEMBL13699894 0.81 MAPT (0.56) HPGDHSD17B10MEN1KMT2AMAPK10
SCHEMBL4254458 0.81 HPGD (0.67) HPGDHSD17B10MEN1KMT2AMAPK10
SCHEMBL13699772 0.80 MEN1 (0.66) HPGDHSD17B10MEN1KMT2AMAPK10
SCHEMBL4250078 0.80 MAPT (0.60) HPGDHSD17B10MEN1KMT2AMAPK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE ADORA2A, ADORA2B, HTR1F HPGD 3251/4885HSD17B10 1250/4885MEN1 4409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.